AZN vs PRTA · P/E 28, $288.38B cap vs rev $1.0M
AstraZeneca PLC (AZN) versus Prothena Corporation plc (PRTA) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
Prothena Corporation plc (PRTA) is a biotechnology company listed on US.
AZN does not have a complete income-statement cache yet.
Latest reported PRTA revenue for 2026-06-30 was $1.0M. Net income was -$18.6M. Revenue was down 98.0% from 2026-03-31 to 2026-06-30. PRTA currently screens at market cap $460.2M.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. PRTA currently screens at market cap $460.2M.
Not investment advice. Open the AZN and PRTA stock pages for the full models.
Not investment advice.